GlassScriptPhysician profile
Jaspreet Singh
NPI 1407297146
$37,865.53
in general payments reported to CMS, 2019-2025
28 companies · $538 in 2025
The $538 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,999 · 2020: $6,937 · 2021: $21K · 2022: $1,365 · 2023: $499 · 2024: $1,203 · 2025: $538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,668 · Travel and Lodging: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,667.65 |
| Travel and Lodging | $572.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $30,112.57 | 2019-2025 | Intracept, Emblem Mri S-Icd, General - Dbs |
| Nevro Corp. | $3,966.59 | 2019-2024 | Senza |
| Abbott Laboratories | $1,366.75 | 2019-2023 | Proclaim |
| Medtronic, INC. | $743.41 | 2022-2025 | Intellis Adaptivestim, Accurian, Vanta Adaptivestim |
| Vertos Medical, INC. | $352.32 | 2019 | |
| Foundation Fusion Solutions, LLC | $289.90 | 2019 | |
| Flowonix Medical Incorporated | $214.91 | 2020 | |
| Medtronic USA, INC. | $180.92 | 2019-2020 | |
| Merz Pharmaceuticals, LLC | $71.66 | 2022-2023 | Xeomin |
| Stimwave Technologies Incorporated | $60.00 | 2019 | |
| Globus Medical, INC. | $55.98 | 2025 | Senza |
| Relievant Medsystems, INC. | $44.81 | 2021-2023 | Intracept |
| Biogen, INC. | $39.39 | 2021-2024 | Vumerity, Tysabri |
| Emd Serono, INC. | $38.88 | 2020-2022 | |
| Nalu Medical, INC. | $37.28 | 2024 | Nalu Neurostimulation System |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $34.88 | 2023 | Sprint Pns System |
| Surgalign Spine Technologies, INC. | $33.05 | 2022 | |
| Livanova USA, INC. | $28.31 | 2022 | |
| Grt US Holding, INC. | $25.74 | 2022 | |
| Mdd US Operations, LLC | $23.46 | 2021 | |
| Novo Nordisk INC | $23.04 | 2022 | |
| Tanabe Pharma America, INC. | $23.01 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $22.23 | 2025 | |
| Saluda Medical Americas, INC. | $21.24 | 2023 | Evoke Scs |
| Biotronik Nro, INC. | $20.58 | 2024 | Prospera |
| Expanding Innovations, INC. | $17.64 | 2025 | X-Pac |
| Ethicon US, LLC | $16.98 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaspreet Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.